Pengtao You

1.1k total citations
46 papers, 823 citations indexed

About

Pengtao You is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Pengtao You has authored 46 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 10 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in Pengtao You's work include Natural product bioactivities and synthesis (8 papers), Pharmacological Effects of Natural Compounds (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Pengtao You is often cited by papers focused on Natural product bioactivities and synthesis (8 papers), Pharmacological Effects of Natural Compounds (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Pengtao You collaborates with scholars based in China, United States and Poland. Pengtao You's co-authors include Wu H, Yanfang Yang, Liu Yan-wen, Feiyue Xing, Fangfang Xu, Yu Xia, Jing Liu, Chong Yuan, Min Yang and Dan Liu and has published in prestigious journals such as Scientific Reports, Free Radical Biology and Medicine and Journal of Ethnopharmacology.

In The Last Decade

Pengtao You

44 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pengtao You China 16 356 122 103 102 96 46 823
Mohamed A. Kandeil Egypt 16 304 0.9× 93 0.8× 110 1.1× 90 0.9× 100 1.0× 44 872
Te-Mao Li Taiwan 18 394 1.1× 71 0.6× 117 1.1× 111 1.1× 142 1.5× 20 877
Yi‐Shiou Chiou Taiwan 22 561 1.6× 83 0.7× 125 1.2× 112 1.1× 168 1.8× 51 1.3k
Vinothkumar Rajamanickam China 23 595 1.7× 138 1.1× 155 1.5× 58 0.6× 83 0.9× 34 1.2k
Angela Ladurner Austria 20 392 1.1× 134 1.1× 67 0.7× 61 0.6× 78 0.8× 30 869
Raghavendra S. Patwardhan India 19 614 1.7× 73 0.6× 78 0.8× 89 0.9× 106 1.1× 35 1.0k
Baoshun Zhang China 17 385 1.1× 173 1.4× 73 0.7× 45 0.4× 106 1.1× 39 809
Soraya Sajadimajd Iran 14 438 1.2× 66 0.5× 76 0.7× 59 0.6× 84 0.9× 46 957
Marjorie Reyes‐Farias Spain 11 370 1.0× 61 0.5× 114 1.1× 64 0.6× 131 1.4× 22 1.1k

Countries citing papers authored by Pengtao You

Since Specialization
Citations

This map shows the geographic impact of Pengtao You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengtao You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengtao You more than expected).

Fields of papers citing papers by Pengtao You

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengtao You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengtao You. The network helps show where Pengtao You may publish in the future.

Co-authorship network of co-authors of Pengtao You

This figure shows the co-authorship network connecting the top 25 collaborators of Pengtao You. A scholar is included among the top collaborators of Pengtao You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengtao You. Pengtao You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Qi, et al.. (2024). Chikusetsusaponin IVa Targets Nrf2 to Inhibit H9N2 Avian Influenza Virus Infection. Pharmacognosy Magazine. 21(2). 584–598. 2 indexed citations
2.
3.
Xiong, Feng, Zheyi Han, Ziqiang Wang, et al.. (2024). 18F-5-fluoro-aminosuberic acid PET/CT imaging of oxidative-stress features during the formation of DEN-induced rat hepatocellular carcinoma. Theranostics. 15(1). 141–154. 2 indexed citations
4.
5.
Hou, Xiaoying, Cong Du, Ligong Lu, et al.. (2022). Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells. World Journal of Surgical Oncology. 20(1). 37–37. 40 indexed citations
6.
Li, Yao, et al.. (2022). Screening of anti-liver fibrosis peptides from turtle shell protein using two-enzyme hydrolysis by molecular docking. Food & Function. 14(3). 1476–1483. 5 indexed citations
7.
Jiang, Siyi, Xiaochuan Ye, Dan Luo, et al.. (2021). The Anti-Inflammatory Effect of Smilax china L. Extract on LPS-Stimulated THP-1 via Downregulation of MAPK and NF-κB Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 5 indexed citations
8.
Yin, Hai-Long, Yu Xia, Wu H, et al.. (2021). Huganbuzure Granule Attenuates Concanavalin-A-Induced Immune Liver Injury in Mice via Regulating the Balance of Th1/Th2/Th17/Treg Cells and Inhibiting Apoptosis. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 6 indexed citations
9.
Yuan, Chong, et al.. (2021). Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer. Life Sciences. 270. 119105–119105. 111 indexed citations
10.
Ma, Xiaoqing, Pengtao You, Yan Xu, et al.. (2020). Anti-Helicobacter pylori-associated gastritis effect of the ethyl acetate extract of Alpinia officinarum Hance through MAPK signaling pathway. Journal of Ethnopharmacology. 260. 113100–113100. 16 indexed citations
11.
You, Pengtao, et al.. (2020). Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl4-induced Liver Fibrosis Rats. Current Medical Science. 40(3). 539–547. 12 indexed citations
12.
Chen, Xin, Yuanchun Ma, Meng-Ling Yang, et al.. (2020). Pharmacokinetics and Tissue Distribution Study of Modified Xiaochaihu Granules Against Gastric Ulcer Induced by Ethanol in Rats by UPLC-MS/MS. Natural Product Communications. 15(7). 1 indexed citations
13.
Xia, Yu, et al.. (2019). <p>14-Deoxycoleon U-induced endoplasmic reticulum stress-mediated apoptosis, autophagy, and cell cycle arrest in lung adenocarcinoma</p>. OncoTargets and Therapy. Volume 12. 5955–5965. 4 indexed citations
14.
Yang, Yanfang, Songtao Wu, Bo Liu, et al.. (2019). A Novel Antiplatelet Aggregation Target of Justicidin B Obtained From Rostellularia Procumbens (L.) Nees. Frontiers in Pharmacology. 10. 688–688. 7 indexed citations
15.
Liu, Wei, Meng-Ling Yang, Xuejian Chen, et al.. (2018). Mechanisms of Antiulcer Effect of an Active Ingredient Group of Modified Xiao Chaihu Decoction. Evidence-based Complementary and Alternative Medicine. 2018(1). 5498698–5498698. 14 indexed citations
16.
Xia, Yu, Bo Yu, Chaozhi Ma, et al.. (2018). Yu Gan Long reduces rat liver fibrosis by blocking TGF-β1/Smad pathway and modulating the immunity. Biomedicine & Pharmacotherapy. 106. 1332–1338. 20 indexed citations
17.
You, Pengtao, Sha Xiong, Jianrong Gao, et al.. (2017). Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling. Biomedicine & Pharmacotherapy. 95. 11–17. 26 indexed citations
18.
Xia, Yu, Pengtao You, Fangfang Xu, Jing Liu, & Feiyue Xing. (2015). Novel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro. Nanoscale Research Letters. 10(1). 1051–1051. 70 indexed citations
19.
You, Pengtao, Feiyue Xing, Baoyu Wang, et al.. (2013). In vitro and in vivo evaluation of anisomycin against Ehrlich ascites carcinoma. Oncology Reports. 29(6). 2227–2236. 12 indexed citations
20.
Cai, Xiaofang, et al.. (2010). ART-induced biophysical and biochemical alterations of Jurkat cell membrane. Micron. 42(1). 17–28. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed A. Kandeil Breakdown of academic impact, for papers by Te-Mao Li Breakdown of academic impact, for papers by Yi‐Shiou Chiou Breakdown of academic impact, for papers by Vinothkumar Rajamanickam Breakdown of academic impact, for papers by Angela Ladurner Breakdown of academic impact, for papers by Raghavendra S. Patwardhan Breakdown of academic impact, for papers by Baoshun Zhang Breakdown of academic impact, for papers by Soraya Sajadimajd Breakdown of academic impact, for papers by Marjorie Reyes‐Farias
Rankless by CCL
2026